doctor, hospital, health

Project ECHO Part 4: Building a Bridge to Subspecialty Care

What Comes Next After Identifying Patients with a Suspected Bleeding Disorder

  • Host/Moderator: Patricia Huguelet, MD
  • Presenter: Genevieve Moyer, MD
  • Target Audience: OB/GYN

Session Objectives

  • Review which patients are suitable for referral to hematology or combined hematology/gynecology subspecialty clinics.
  • Discuss diagnosis and management strategies that can be started before this subspecialty visit takes place.


Time Presentation Presenters
11:00 – 11:02 AM EST Welcome, Introductions, and Housekeeping Patricia Huguelet, MD
11:02 – 11:22 AM EST Building a Bridge to Subspecialty Care: What Comes Next After Identifying Patients with a Suspected Bleeding Disorder Genevieve Moyer, MD
11:22 – 11:27 AM EST Question and Answer Genevieve Moyer, MD
11:27 – 11:42 AM EST Case Presentation Patricia Huguelet, MD
Genevieve Moyer, MD
11:42 – 11:47 AM EST Clarifying Questions Patricia Huguelet, MD
Genevieve Moyer, MD
11:47 – 11:57 AM EST Recommendations Genevieve Moyer, MD
11:57 – 11:59 AM EST Wrap-Up Patricia Huguelet, MD
11:59 – 12:00 PM EST Closing Remarks Patricia Huguelet, MD


PHI All patient information will be de-identified during the ECHO session.
Recording This session may be audio and video recorded. Your participation confirms your consent to this recording.
Continuing Medical Education (CME) Credit 1 Hour

This project is supported by cooperative agreement DD000008 from the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of an annual financial assistance award totaling $320,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

In support of improving patient care, this activity has been planned and implemented by the Hemophilia Federation of America and Project ECHO. Project ECHO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Designation Statement

Project ECHO® designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Designation Statement

Project ECHO® designates this live activity for a maximum of 1.0 ANCC contact hours. Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation.

Disclosure Statement

Project ECHO®, in compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, requires that anyone who is in a position to control the content of an educational activity disclose all relevant financial relationships they have had within the last 24 months with an ineligible company.
None of the planners and presenters for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.


  • Jacey Gonzalez, BA
  • Anne Goodman, MPH
  • G Shellye Horowitz, MA
  • Kristina Haley, DO MCR
  • Lori Long, BS
  • Patricia Huguelet, MD
  • Whitney Armijo, BS
  • Janet Chupka, RN, BSN


  • Patricia Huguelet, MD
  • Genevieve Moyer, MD

The planners/presenters listed below have disclosed that they have a relevant financial relationship with an ineligible company.

Name Nature of Relationship Name of Ineligible Company
Skye Peltier, MPH, PA-C Advisor and Speaker Novo Nordisk
Skye Peltier, MPH, PA-C Advisor Sanofi
Stormy Johnson Independent Contractor and Speaker Medexus Pharmaceutical
Stormy Johnson Employee Paragon Healthcare
Kristina Haley, DO, MCR Principal Investigator ATHN & HTRS

All of the relevant financial relationships listed for these individuals have been mitigated.


Nov 09 2022


Eastern Time
11:00 am - 12:00 pm

More Info

Register Today
Register Today


  • Genevieve Moyer, MD
    Genevieve Moyer, MD

    Dr. Moyer attended medical school and did her residency at the Saint Louis University School of Medicine. Early in her career she studied the venous thromboembolism characteristics of individuals who received stem cell transplantation, focusing on differences between cord blood and non-cord blood recipients. This led to her discovering that not only was post-transplant thrombosis a serious problem, but that these patients were also at an extremely high risk of bleeding with anticoagulation. As a result, she developed a career interest aimed at developing tools to risk-stratify complex patients regarding their risk for bleeding and clotting simultaneously. As her career progressed, she discovered a passion for the treatment of women with bleeding disorder, which led to a goal of balancing knowledge and understanding of bleeding disorders across genders.

    Dr. Moyer believes strongly in the importance of getting to know each patient as an individual and engaging them in shared decision making. To accomplish this, she strives to ensure that all of her patients understand their diagnosis so that they feel empowered in the pursuit of their own health and wellness.

    Her medical specialty is classical hematology with an emphasis on hemostasis and thrombosis. She is committed to improving the management of women, transgender, and gender non-binary individuals with bleeding disorders. Her primary research endeavors are focused on these populations with an overarching goal of developing novel risk stratification tools that can predict future bleeding and thrombotic events and help guide medical management.

QR Code